These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: A mini review of scientific and pharmacopeial requirements for the disintegration test.
    Author: Donauer N, Löbenberg R.
    Journal: Int J Pharm; 2007 Dec 10; 345(1-2):2-8. PubMed ID: 17935916.
    Abstract:
    Disintegration is a performance test for oral dosage forms that is described in the United States Pharmacopeia (USP), the European Pharmacopeia (EP) and the Japanese Pharmacopeia (JP, chapter 14, 2001). This review lists changes that have been made since the USP 23 and compares them to those in the USP 30, EP 5.3 and JP XIV. The differences between the disintegration test methods in the three pharmacopeias are discussed. Examples are provided where disintegration can be used as a performance test for ensuring the drug release.
    [Abstract] [Full Text] [Related] [New Search]